Ratio may help identify aggressive prostate cancers
Minneapolis-For decades, the Gleason grading system has been the de facto standard used to characterize prostatic tumors. Now, with the help of Donald F. Gleason, MD, himself, researchers from the University of Minnesota have found a way to make the system even more useful to clinicians.
Recent Videos
Related Content
Ra223 plus SABR does not delay progression of oligometastatic HSPC
October 3rd 2024Article
"The addition of radium-223 to SABR metastasis-directed therapy in low-volume bone-metastatic hormone-sensitive prostate cancer does not delay progression of disease in the RAVENS study," said Ana Kiess, MD, PhD.
